Post-approval studies (Phase 4)Not Yet RecruitingNCT07203664
What this trial is testing
Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.
Who this might be right for
Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
Hospital Universitario La Paz 30